lysophosphatidic acid has been researched along with Lung Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, G; Damirin, A; Li, Y; Ma, Q; Pei, JY; Sun, HJ; Wang, YW; Wu, S; Zhao, PF | 1 |
| Jangde, N; Rai, V; Ray, R; Singh, SK; Sinha, S | 1 |
| Ae, K; Fujita, N; Funauchi, Y; Haraguchi, M; Katayama, R; Kawaguchi, T; Koike, S; Matsumoto, S; Saito, M; Sasaki, Y; Seto, Y; Sugawara, M; Takagi, S; Takemoto, A; Ukaji, T | 1 |
| Araki, M; Dong, Y; Fukushima, N; Hirane, M; Kitayoshi, M; Tanabe, E; Tsujiuchi, T | 1 |
| Benesch, MG; Brindley, DN; Curtis, JM; Dewald, J; Hitt, M; Kok, BP; Maeda, T; McMullen, TP; Ohhata, A; Tang, X; Zhao, YY | 1 |
| Berliner, C; Bialecki, W; Kleuser, B; Leptin, J; Milićević, NM; Müller, R; Pörtner, D; Schumacher, U | 1 |
| Fukushima, N; Hayashi, M; Honoki, K; Mori, T; Okabe, K; Teranishi, M; Tsujiuchi, T; Yamawaki, Y | 1 |
| Heo, SC; Kim, IS; Kim, J; Kim, JH; Kim, YM; Kwon, YW; Lee, TG; Shin, SH | 1 |
| Do, EK; Heo, SC; Kim, JH; Kim, KH; Kim, YM; Kwon, YW; Shin, SH; Suh, DS; Yoon, MS | 1 |
| Chen, H; Ding, J; Lang, JY; Li, MH; Lin, LP; Waalkes, MP; Zhang, JS; Zhang, XW; Zhang, YX; Zhou, J | 1 |
| Brindley, DN; Hurst-Kennedy, J; Murph, MM; Newton, V; Radhakrishna, H | 1 |
| Baker, DL; Banerjee, S; Lee, SC; Miller, DD; Norman, DD; Parrill, AL; Pham, TC; Tigyi, GJ | 1 |
12 other study(ies) available for lysophosphatidic acid and Lung Neoplasms
| Article | Year |
|---|---|
LPA receptor1 antagonists as anticancer agents suppress human lung tumours.
Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Movement; Gene Knockdown Techniques; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Isoxazoles; Lung Neoplasms; Lysophospholipids; Male; MAP Kinase Signaling System; Mice; NF-kappa B; Propionates; Receptors, Lysophosphatidic Acid; Xenograft Model Antitumor Assays | 2020 |
Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Gene Knockdown Techniques; Humans; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Lysophospholipids; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Proto-Oncogene Proteins c-akt; Receptor for Advanced Glycation End Products; Signal Transduction; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |
Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis.
Topics: Blood Platelets; Humans; Lung Neoplasms; Lysophospholipids; Osteosarcoma; Transcriptional Activation | 2021 |
Downregulation of activation factors of endothelia and fibroblasts via lysophosphatidic acid signaling in a mouse lung cancer LL/2 cell line.
Topics: 3T3 Cells; Animals; Cell Movement; Endothelial Cells; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lysophospholipids; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms, Experimental; Neovascularization, Pathologic; Receptors, Lysophosphatidic Acid; Signal Transduction; Vascular Endothelial Growth Factor A | 2013 |
Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice.
Topics: Animals; Carbolines; Cell Line, Tumor; Cell Proliferation; Female; Lung Neoplasms; Lysophospholipids; Mammary Neoplasms, Experimental; Mice; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases | 2014 |
Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells.
Topics: Animals; Breast Neoplasms; Colonic Neoplasms; Endothelium, Vascular; Female; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lysophospholipids; Melanoma; Mice; Mice, SCID; Neoplasm Transplantation; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sphingosine; Transplantation, Heterologous; Tumor Cells, Cultured; Umbilical Cord | 2010 |
Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Methylation; Gene Expression Regulation, Neoplastic; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Lysophospholipids; Mutation; Neoplasms; Rats; Receptors, Lysophosphatidic Acid | 2011 |
Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.
Topics: Adenocarcinoma; Adipose Tissue; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Culture Media, Conditioned; Extracellular Matrix Proteins; Humans; Lung Neoplasms; Lysophospholipids; Mesenchymal Stem Cells; Paracrine Communication; Proteome; Proteomics; Receptors, Lysophosphatidic Acid; rho-Associated Kinases; Tandem Mass Spectrometry; Transforming Growth Factor beta; Tumor Cells, Cultured | 2012 |
Lysophosphatidic acid-induced ADAM12 expression mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth.
Topics: Actins; ADAM Proteins; ADAM12 Protein; Adenocarcinoma; Adenocarcinoma of Lung; Adipose Tissue; Animals; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Extracellular Matrix Proteins; Fibroblasts; Gene Silencing; Humans; Lung Neoplasms; Lysophospholipids; Membrane Proteins; Mesenchymal Stem Cells; Mice; Mice, Nude; Neoplasms; Receptors, Lysophosphatidic Acid; RNA, Small Interfering; Transforming Growth Factor beta; Xenograft Model Antitumor Assays | 2012 |
Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Topics: Animals; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cytosol; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lysophospholipids; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Naphthoquinones; Protein Transport; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; rhoC GTP-Binding Protein; RNA, Messenger; Signal Transduction; Stress Fibers; Xenograft Model Antitumor Assays | 2005 |
Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A549 lung carcinoma cells.
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Nucleus; DNA Damage; Humans; Lung Neoplasms; Lysophospholipids; Mitogens; Neoplasms; Receptors, Lysophosphatidic Acid; Transcription, Genetic; Tumor Suppressor Protein p53 | 2007 |
Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.
Topics: Animals; Antineoplastic Agents; Benzenesulfonamides; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Lung; Lung Neoplasms; Melanoma; Mice; Models, Molecular; Neoplasm Invasiveness; Neoplastic Stem Cells; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship; Sulfonamides | 2017 |